Abstract:Introduction: Traditionally, Callicarpa species have been utilized their anti-inflammatory and hemostatic properties. Prominently featured species in the 2020 Edition of the Chinese Pharmacopoeia were Callicarpa nudiflora (CN), Callicarpa macrophylla (CM), Callicarpa formosana (CF), and Callicarpa kwangtungensis (CK), which were formulated into several medicinal preparations. Extensive applications led to the significant depletion of CN's wild resources. The management of germplasm resources was significantly disordered. Adulteration issues were also prevalent. Objective: It is imperative that the study aims to identify alternative sources for CN and other pharmacopeial varieties and develop methods to distinguish different Callicarpa species. Results: Data were acquired using three mass spectrometry modes: Data Dependent Analysis (DDA), Data-Independent Analysis (DIA), and full mass spectrometry (MS). The DDA mode identified or inferred information on 54 compounds. The Full MS mode identified or inferred 74 compounds, including 20 that were previously unreported in Callicarpa. These compounds were confirmed using standards. The DIA mode did not facilitate identification due to missing precursor ion data. With metabolomics, 19 differential compounds were identified or inferred. Luteolin, chrysoeriol, and quercetin were selected as potential markers, integrating the 10 active compounds from network pharmacology. Conclusion: Based on the relative abundance of these markers, it was proposed that Callicarpa giraldii Hesse ex Rehd. var. (CGHRV) and CM could serve as alternative resource species to CN, while CGHRV and Callicarpa giraldii Hesse ex Rehd. (CGHR) could substitute the pharmacopeial CM. Callicarpa longissimi (CLG) was suggested as an alternative to CK, while Callicarpa cathayana (CC) and Callicarpa rubella (CRL) could replace CF. Furthermore, the absence of certain compounds in CK presented a novel opportunity for the differentiation of various Callicarpa species.

Callicarpa yongshunensis (Lamiaceae): A new species from Hunan, China

Didymocarpus Longicalyx (gesneriaceae), a New Species from Southwestern Yunnan, China

Salvia glabrifolia (Lamiaceae), a new species from Hunan, China

Carex Qingliangensissp. Nov. (cyperaceae) from Zhejiang, Eastern China

Calanthe yingjiangensis (Epidendroideae; Orchidaceae), a new species from China: evidence from morphological and molecular data

Elsholtzia Zhongyangii (lamiaceae), a New Species from Sichuan, China

<i>Smilax weniae</i>, a New Species of Smilacaceae from Limestone Areas Bordering Guizhou and Guangxi, China

Carex Yandangshanica Sp. Nov. (cyperaceae; C. Sect. Rhomboidales) from Zhejiang, China

Cerastium Qingliangfengicum (caryophyllaceae), a New Species from Zhejiang, China

Phytochemical analysis of different Callicarpa species based on integrating metabolomics and chemometrics

Lysimachia xuyongensis (Primulaceae), a new species from Sichuan, China

A new species of Dichocarpum (Ranunculaceae) from northeastern Yunnan, China

A New Species of Chrysosplenium (saxifragaceae) from Zhangjiajie, Hunan, Central China

Utricularia Mangshanensis (lentibulariaceae), A New Species from Hunan, China

A new species of Prunus subgen. Cerasus from Central China

<i>Diplocarpa constans sp. nov</i>., a new species of Cordieritidaceae from Yunnan, China

Ligularia lushuiensis (Asteraceae, Senecioneae), a new species from northwestern Yunnan, China

A new species and a replacement name in Cynanchum (Apocynaceae, Asclepiadeae) from China

Sinosenecio Hupingshanensis (asteraceae), A New Species from Hunan and Hubei, China

Polygalaqii, a new species of Polygalaceae from limestone landform in Southern Hunan, China

<i>Cortiella</i><i> yatungense,</i> a new species of<i> Cortiella</i> (Apiaceae) from Xizang, China